Pharmaceutical Executive-07-01-2004

Pharmaceutical Executive

Pricing Climate Heats Up in US and Europe

July 01, 2004

Features

In 2003, Big Pharma produced only a dozen new drugs. At the same time, it came under new pressure to create value from those thin pipelines. In that "hot squeeze" of a climate, pharma companies needed price premiums for every product in every market. They were more successful in some countries than in others. Other pricing trends also took their toll.

July 2004 Table of Contents

July 01, 2004

July 2004 Table of Contents